関連する実験動画
Updated: Feb 14, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
19.9K
退院時の動物命名テストは,選択的なTIPSの後,肝臓脳病と関連しています
Melisande Jorus1, Philippe Sultanik1,2, Charlotte Bouzbib1,2
1Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Intensive Care Unit, Hepatology Department, Paris, France.
JHEP reports : innovation in hepatology
|February 13, 2026
まとめ
トランジューギュラ・イントラヘパティック・ポートシステムシャント (TIPS) 置換後の動物命名テスト (ANT) は,公然とした肝臓脳症 (OHE) を予測することができます. 解約時により低いANTスコアは,TIPS後のOHEを発症するリスクが高いことを示します.
科学分野:
- 肝臓病理学 肝臓病理学
- 神経学 神経学とは
- 医療診断 医療診断
背景:
- オープン肝臓脳症 (OHE) は,横関節内肝臓移植システムシャント (TIPS) 術後の重大な合併症である.
- OHEのリスクを予測することは,TIPS後の患者管理において極めて重要です.
研究 の 目的:
- 選択的なTIPS配置後にOHEを予測する動物命名テスト (ANT) の有用性を評価する.
- OHE開発のTIPS後の信頼性の高い予測要因を特定する.
主な方法:
- ANT (1分間の持続時間) は,TIPSの前に100人の患者に投与され,退院時に,および手続後1,3,および6ヶ月で投与されました.
- 多変量分析を使用して,OHEの独立した予測要因を特定し,死亡や肝臓移植などの競合するリスクを考慮しました.
主要な成果:
- TIPS以前のANTは予測的ではなかったが,排出時のANT (HR 0.89,p=0.005) とTIPS後のアンモニアレベルはOHEの有意な予測者であった.
- 放出時のANTの1ポイントの減少は,OHEの8%のリスク増加と関連していました.
- OHEの独立した予測要因には,年齢,TIPS以前のアンモニア,排出アンモニア,排出時のANTが含まれていました.
結論:
- 退院時に実施された動物命名試験は,TIPS後にOHEのリスクが増加した患者を特定する有望な結果を示しています.
- 定期的なTIPS ANT後の評価は,早期のリスク分層化に役立ち,予防戦略を導くことができます.
関連する概念動画
02:21Naming Enantiomers
26.2K
The naming of enantiomers employs the Cahn–Ingold–Prelog rules that involve assigning priorities to different substituent groups at a chiral center. Each enantiomer, being a distinct molecule, is assigned a unique name by the Cahn–Ingold–Prelog (CIP) rules, also called the R–S system. The prefix R- or S- attached to the chiral centers in an enantiomer is dependent on the spatial arrangement of the four substituents on the chiral center. The R–S system essentially comprises three...
26.2K
01:31Discharge Summary Forms
1.3K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
01:19Naming Skeletal Muscles
4.1K
The naming of the approximately 700 muscles in the human body is based on a set of criteria designed to provide descriptive information about each muscle, making it easier to identify and remember them.
The key factors used in naming muscles include:
The key factors used in naming muscles include:
4.1K
01:11Common Names of Aldehydes and Ketones
5.1K
Some common aldehydes and ketones are popularly known by their common names used historically and predate the IUPAC nomenclature.
Common names of aldehydes are derived from the names of their corresponding acid. For instance, the two-carbon aldehyde–acetaldehyde derives its name from the corresponding acid–acetic acid. Similarly, formaldehyde derives its name from formic acid and benzaldehyde from benzoic acid.
Aliphatic ketones are named by suffixing the word “ketone” to the...
Common names of aldehydes are derived from the names of their corresponding acid. For instance, the two-carbon aldehyde–acetaldehyde derives its name from the corresponding acid–acetic acid. Similarly, formaldehyde derives its name from formic acid and benzaldehyde from benzoic acid.
Aliphatic ketones are named by suffixing the word “ketone” to the...
5.1K
01:27RC Circuits: Discharging A Capacitor
4.5K
One of the applications of an RC circuit is the relaxation oscillator. The relaxation oscillator comprises a voltage source, a capacitor, a resistor, and a neon lamp. The lamp acts like an open circuit (infinite resistance) until the potential difference across the neon lamp reaches a specific voltage. At that voltage, the lamp acts like a short circuit (zero resistance), and the capacitor discharges through the neon lamp and produces light. Once the capacitor is fully discharged through the...
4.5K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281